XML 67 R21.htm IDEA: XBRL DOCUMENT

Leases and Other Commitments	12 Months Ended
Sep. 30, 2014
Commitments and Contingencies Disclosure [Abstract]
Commitments Disclosure [Text Block]	Note 10. Leases and Other Commitments At September 30, 2014, future minimum payments totaling $338.3 million under noncancelable operating leases with remaining terms of more than one fiscal year were due as follows: 2015 — $58.2 million; 2016 — $54.4 million; 2017 — $44.7 million; 2018 — $41.2 million; 2019 — $34.2 million; and thereafter — $105.6 million. In the normal course of business, operating leases are generally renewed or replaced by other leases. Certain operating leases include escalation clauses. Total rental expense was $81.8 million in fiscal 2014, $79.6 million in fiscal 2013, and $65.3 million in fiscal 2012. The Company has commitments to purchase product from influenza vaccine manufacturers through the 2015/2016 flu season. The Company is required to purchase doses at prices it believes will represent market prices. The Company currently estimates its remaining purchase commitment under these agreements will be approximately $72.9 million as of September 30, 2014, of which $57.2 million represents the Company's commitment in fiscal 2015. The Company outsources to IBM Global Services (“IBM”) a significant portion of its corporate and AmerisourceBergen Drug Corporation information technology activities. The remaining commitment under the Company's arrangement, as amended in May 2014, which expires in June 2018, is approximately $74.1 million as of September 30, 2014, of which $37.1 million represents the Company's commitment in fiscal 2015.

Leases and Other Commitments

12 Months Ended

Sep. 30, 2014

Commitments and Contingencies Disclosure [Abstract]

Note 10. Leases and Other Commitments

At September 30, 2014, future minimum payments totaling $338.3 million under noncancelable operating leases with remaining terms of more than one fiscal year were due as follows: 2015 — $58.2 million; 2016 — $54.4 million; 2017 — $44.7 million; 2018 — $41.2 million; 2019 — $34.2 million; and thereafter — $105.6 million. In the normal course of business, operating leases are generally renewed or replaced by other leases. Certain operating leases include escalation clauses. Total rental expense was $81.8 million in fiscal 2014, $79.6 million in fiscal 2013, and $65.3 million in fiscal 2012.

The Company has commitments to purchase product from influenza vaccine manufacturers through the 2015/2016 flu season. The Company is required to purchase doses at prices it believes will represent market prices. The Company currently estimates its remaining purchase commitment under these agreements will be approximately $72.9 million as of September 30, 2014, of which $57.2 million represents the Company's commitment in fiscal 2015.

The Company outsources to IBM Global Services (“IBM”) a significant portion of its corporate and AmerisourceBergen Drug Corporation information technology activities. The remaining commitment under the Company's arrangement, as amended in May 2014, which expires in June 2018, is approximately $74.1 million as of September 30, 2014, of which $37.1 million represents the Company's commitment in fiscal 2015.

- Definition

The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.

+ References+ Details